| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |